If you’ve ever wondered, “Am I getting tested often enough?” you’re not alone. Between work, school, hookups, and everything ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

The likelihood of a twice-yearly PrEP injection moved closer this week. Gilead released the results of a new trial into its HIV drug: lenacapavir. The medication is already used as an HIV treatment.

July 13, 2011 — In another major advance against the spread of HIV/AIDS, 2 studies released today report that a daily dose of antiretroviral drugs used to treat HIV infection also can reduce the ...

Please provide your email address to receive an email when new articles are posted on . Survey results showed that transgender women and transfeminine nonbinary people support OTC PrEP. Lauren ...

GSK’s ViiV Healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (PrEP) ...

Nearly one in three gay and bisexual men who were diagnosed with HIV at UK sexual health clinics didn't meet the criteria for "high risk" that would signal to a clinician that they would be good ...

GLAAD--the world's largest lesbian, gay, bisexual, transgender, and queer (LGBTQ) media advocacy organization––invited Snoop Dogg to JSU.

A new jab, which will help prevent HIV transmissions, has been described as a ‘game changer’ by an LGBT charity in Northern ...